The success of Viagra initially fueled a boom for major pharmaceutical companies, but recent developments present a uncertain picture for investors. Off-patent alternatives are eating into earnings, and persistent https://anitardrm032517.theisblog.com/41603846/sildenafil-and-big-pharma-a-precarious-play